MCINAW MICHAEL enters AEVI GENOMIC MEDICINE, LLC with 16.11K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 16.11K | Direct |
| Total | 16.11K | 16.11K direct |
Stock Option (right to buy)
DirectUnderlying shares
6.50K
Shares owned
N/A
Exercise price
5.77
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
6.50K
Shares owned
N/A
Exercise price
1.52
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
5K
Shares owned
N/A
Exercise price
1.24
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
26.25K
Shares owned
N/A
Exercise price
1.55
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
5K
Shares owned
N/A
Exercise price
1.32
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
1.50K
Shares owned
N/A
Exercise price
4.91
Expiration
—
Exercise window
—
Underlying
50.75K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 5.77 | — | — | 6.50K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 1.52 | — | — | 6.50K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 1.24 | — | — | 5K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 1.55 | — | — | 26.25K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 1.32 | — | — | 5K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 4.91 | — | — | 1.50K | N/A |
| Total | 50.75K | 0.00 | ||||